NGS-based assays & reagents

       NGS technologies have made high throughput and high sensitivity DNA sequencing possible. Millions of sequences are produced in a single next-generation sequencing process with a large amount of data in a short time. They are highly sensitive and accurate.

       LymphoTrack® assays kits are  lymphoma diagnosis and detection assay kits developed by Invivoscribe Inc. based on NGS technologies and are the only next-generation sequencing assay kits in BIOMED-2 protocols. These kits are designed specifically for commonly used next-generation analyzers Life Technologies Ion PGM™ and Illumina MiSeq®, and iareapplicable to all-platform NGS.

       LymphoTrack® Assays significantly outperform the existing clonality assays available in the market. Ig/TCR gene analysis enables lymphoma rearrangements, somatic hypermutation and MRD detection at the same time. LymphoTrack® Assays have practical applications in a wide variety of fields including lymphoma diagnosis, genetic lineage identification, prognosis and MRD monitoring, etc.

Product list